Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2022 Results - Earnings Call Transcript

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET

Company Participants

Mercedes Carrasco - Director, Corporate Communications
John Butler - CEO, President & Director
David Spellman - SVP, CFO & Treasurer

Conference Call Participants

Allison Bratzel - Piper Sandler & Co.
Mara Goldstein - Mizuho Securities
Antonio Arce - H.C. Wainwright & Co.
Rohit Bhasin - Needham

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Akebia First Quarter 2022 Financial Results Conference Call. [Operator Instructions].

I would now like to hand the conference over to your speaker today, Mercedes Carrasco, Director of Corporate Communications. Please go ahead, ma'am.

Mercedes Carrasco

Thank you -- thank you and welcome to Akebia's first quarter 2022 financial results and business update conference call. Please note that a press release was issued earlier today, Monday, May 9th, detailing our first quarter financial results, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will be available on our website shortly after we conclude. Joining me for today's call, we have John Butler, Chief Executive Officer; and Dave Spellman, Chief Financial Officer.

Before we begin, I'd like to remind everyone that this call includes forward-looking statements. Each forward-looking statement on this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information describing these risks is included in the financial results, financial results press release that we issued on May 9th, as well as in the Risk Factors and Management Discussion and Analysis section of our most recent annual and quarterly reports filed with the SEC. The forward-looking statements on this call speak only as to the original date of this call, and except as required by law. We do not